Universal Biosensors, Inc. (ASX:UBI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0220
-0.0020 (-8.33%)
Aug 1, 2025, 3:31 PM AEST

Universal Biosensors Company Description

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.

The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO₂, malic acid, glucose, fructose, total acid, and titratable acidity.

It also provides non-diagnostic laboratory services and coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans.

Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.

Universal Biosensors, Inc.
CountryUnited States
Founded2001
IndustryMedical Devices
SectorHealthcare
Employees76
CEOPeter Mullin

Contact Details

Address:
1 Corporate Avenue
Rowville, Delaware 3178
Australia
Phone61 3 9213 9000
Websiteuniversalbiosensors.com

Stock Details

Ticker SymbolUBI
ExchangeAustralian Securities Exchange
Fiscal YearJanuary - December
Reporting CurrencyAUD
ISIN NumberAU000000UBI2
SIC Code2835

Key Executives

NamePosition
Peter MullinMD, Chief Executive Officer, Finance Director, Chief Financial Officer, Company Secretary and Director
Salesh Balak B.A., BA, C.A., CACompany Secretary and Corporate Advisor
Luke Cossins B.Sc., M.B.A.C.T.O
Keith SimsGlobal Marketing Director
Anthony Soha B.A.Head of Sales
Ann Chew B.Com., CPA, CIAHead of People Strategy and Culture